liraglutide depot (NN9223) / Novo Nordisk  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
liraglutide depot (NN9223) / Novo Nordisk
NCT01473953: Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Completed
1
31
US
liraglutide-depot, placebo
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2, Healthy
03/12
03/12

Download Options